The partnership places Dimora Medical within a specialized council dedicated to reducing the prevalence of pressure ulcers among high-risk populations, including the elderly and critically ill. By aligning with the NPIAP, the company aims to move beyond product supply, shifting its focus toward knowledge exchange and the standardization of prevention protocols in long-term and intensive care settings.

Central to this collaboration is the deployment of the MegaSorb silicone foam dressing. The technology utilizes a high-porosity polymer structure capable of absorbing 15 times its own weight in fluid. By facilitating consistent exudate management and reducing the frequency of dressing changes, the system is designed to minimize skin trauma in vulnerable areas such as the sacrum and heel. This technical approach serves as the practical foundation for Dimora’s broader mission to lower the clinical burden on nursing staff while improving patient outcomes.